Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DLR vs MRNA✓SelectedUSD · MRNADLR vs MRNA performance historyLatest closeAs of-6.64%11/20
Stock and ETF performance explorer

DLR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-13.6%
MRNA return
+323.5%
Excess return
-337.2%
Maximum drawdown
-18.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-6.6%-2.2%-4.5%-6.6%
7D-9.7%-12.7%+3.0%-9.8%
30D-7.9%-20.7%+12.8%-7.9%
3M-15.8%+46.3%-62.1%-15.4%
6M-13.6%+305.2%-318.9%-14.6%
All-13.6%+323.5%-337.2%-14.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling